Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Share this content:
Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
 
Sponsors and Collaborators
National Cancer Institute (NCI)
 
Contact
NCI Referral Office    
1-888-NCI-1937
 
ClinicalTrials.gov Identifier
NCT00923130
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters